TransCode Therapeutics has developed an iron oxide nanoparticle–based therapeutic RNA delivery system that maximizes targeted tumor uptake while minimizing clearance. With a lead candidate in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback